| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |